 | • レポートコード：QYR9N7929 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ラニビズマブのグローバル市場について調査・分析したレポートで、種類別（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル）、用途別（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ラニビズマブの世界市場規模 ・主要企業別市場シェア ・ラニビズマブの世界市場規模：種類別（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル） ・ラニビズマブの世界市場規模：用途別（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO） ・ラニビズマブのアメリカ市場規模（種類別、用途別） ・ラニビズマブのヨーロッパ市場規模（種類別、用途別） ・ラニビズマブの中国市場規模（種類別、用途別） ・ラニビズマブの日本市場規模（種類別、用途別） ・ラニビズマブの東南アジア市場規模（種類別、用途別） ・ラニビズマブのインド市場規模（種類別、用途別） ・ラニビズマブの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ラニビズマブの世界市場予測（2019年-2025年） ・ラニビズマブの地域別市場予測（2019年-2025年） ... |
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.In 2018, the global Ranibizumab market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Ranibizumab status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ranibizumab development in United States, Europe and China.
The key players covered in this study
Genentech
Novartis
…
Market segment by Type, the product can be split into
Single-use prefilled syringe
Single-use glass vial
Market segment by Application, split into
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ranibizumab status, future forecast, growth opportunity, key market and key players.
To present the Ranibizumab development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ranibizumab are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ranibizumab Market Size Growth Rate by Type (2014-2025)
1.4.2 Single-use prefilled syringe
1.4.3 Single-use glass vial
1.5 Market by Application
1.5.1 Global Ranibizumab Market Share by Application (2014-2025)
1.5.2 wAMD
1.5.3 Diabetic Retinopathy (DR)
1.5.4 Diabetic Macular Edema (DME)
1.5.5 mCNV
1.5.6 RVO
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ranibizumab Market Size
2.2 Ranibizumab Growth Trends by Regions
2.2.1 Ranibizumab Market Size by Regions (2014-2025)
2.2.2 Ranibizumab Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ranibizumab Market Size by Manufacturers
3.1.1 Global Ranibizumab Revenue by Manufacturers (2014-2019)
3.1.2 Global Ranibizumab Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
3.2 Ranibizumab Key Players Head office and Area Served
3.3 Key Players Ranibizumab Product/Solution/Service
3.4 Date of Enter into Ranibizumab Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ranibizumab Market Size by Type (2014-2019)
4.2 Global Ranibizumab Market Size by Application (2014-2019)
5 United States
5.1 United States Ranibizumab Market Size (2014-2019)
5.2 Ranibizumab Key Players in United States
5.3 United States Ranibizumab Market Size by Type
5.4 United States Ranibizumab Market Size by Application
6 Europe
6.1 Europe Ranibizumab Market Size (2014-2019)
6.2 Ranibizumab Key Players in Europe
6.3 Europe Ranibizumab Market Size by Type
6.4 Europe Ranibizumab Market Size by Application
7 China
7.1 China Ranibizumab Market Size (2014-2019)
7.2 Ranibizumab Key Players in China
7.3 China Ranibizumab Market Size by Type
7.4 China Ranibizumab Market Size by Application
8 Japan
8.1 Japan Ranibizumab Market Size (2014-2019)
8.2 Ranibizumab Key Players in Japan
8.3 Japan Ranibizumab Market Size by Type
8.4 Japan Ranibizumab Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ranibizumab Market Size (2014-2019)
9.2 Ranibizumab Key Players in Southeast Asia
9.3 Southeast Asia Ranibizumab Market Size by Type
9.4 Southeast Asia Ranibizumab Market Size by Application
10 India
10.1 India Ranibizumab Market Size (2014-2019)
10.2 Ranibizumab Key Players in India
10.3 India Ranibizumab Market Size by Type
10.4 India Ranibizumab Market Size by Application
11 Central & South America
11.1 Central & South America Ranibizumab Market Size (2014-2019)
11.2 Ranibizumab Key Players in Central & South America
11.3 Central & South America Ranibizumab Market Size by Type
11.4 Central & South America Ranibizumab Market Size by Application
12 International Players Profiles
12.1 Genentech
12.1.1 Genentech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ranibizumab Introduction
12.1.4 Genentech Revenue in Ranibizumab Business (2014-2019)
12.1.5 Genentech Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ranibizumab Introduction
12.2.4 Novartis Revenue in Ranibizumab Business (2014-2019)
12.2.5 Novartis Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Ranibizumab Key Market Segments
Table Key Players Ranibizumab Covered
Table Global Ranibizumab Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ranibizumab Market Size Market Share by Type 2014-2025
Figure Single-use prefilled syringe Figures
Table Key Players of Single-use prefilled syringe
Figure Single-use glass vial Figures
Table Key Players of Single-use glass vial
Table Global Ranibizumab Market Size Growth by Application 2014-2025 (Million US$)
Figure wAMD Case Studies
Figure Diabetic Retinopathy (DR) Case Studies
Figure Diabetic Macular Edema (DME) Case Studies
Figure mCNV Case Studies
Figure RVO Case Studies
Figure Ranibizumab Report Years Considered
Table Global Ranibizumab Market Size 2014-2025 (Million US$)
Figure Global Ranibizumab Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ranibizumab Market Size by Regions 2014-2025 (Million US$)
Table Global Ranibizumab Market Size by Regions 2014-2019 (Million US$)
Table Global Ranibizumab Market Share by Regions 2014-2019
Figure Global Ranibizumab Market Share by Regions 2014-2019
Figure Global Ranibizumab Market Share by Regions 2019
Table Market Top Trends
Table Global Ranibizumab Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ranibizumab Market Share by Manufacturers (2014-2019)
Figure Global Ranibizumab Market Share by Manufacturers in 2018
Table Global Ranibizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ranibizumab Product/Solution/Service
Table Date of Enter into Ranibizumab Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table Global Ranibizumab Market Size Share by Type (2014-2019)
Figure Global Ranibizumab Market Size Market Share by Type (2014-2019)
Table Global Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table Global Ranibizumab Market Size Share by Application (2014-2019)
Figure Global Ranibizumab Market Size Market Share by Application (2014-2019)
Figure Global Ranibizumab Revenue Market Share by Application in 2018
Figure United States Ranibizumab Market Size 2014-2019 (Million US$)
Table United States Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table United States Key Players Ranibizumab Market Share (2018-2019)
Table United States Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table United States Ranibizumab Market Share by Type (2014-2019)
Table United States Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table United States Ranibizumab Market Share by Application (2014-2019)
Figure Europe Ranibizumab Market Size 2014-2019 (Million US$)
Table Europe Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table Europe Key Players Ranibizumab Market Share (2018-2019)
Table Europe Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table Europe Ranibizumab Market Share by Type (2014-2019)
Table Europe Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table Europe Ranibizumab Market Share by Application (2014-2019)
Figure China Ranibizumab Market Size 2014-2019 (Million US$)
Table China Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table China Key Players Ranibizumab Market Share (2018-2019)
Table China Ranibizumab Market Size by Type (2014-20189) (Million US$)
Table China Ranibizumab Market Share by Type (2014-2019)
Table China Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table China Ranibizumab Market Share by Application (2014-2019)
Figure Japan Ranibizumab Market Size 2014-2019 (Million US$)
Table Japan Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table Japan Key Players Ranibizumab Market Share (2018-2019)
Table Japan Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table Japan Ranibizumab Market Share by Type (2014-2019)
Table Japan Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table Japan Ranibizumab Market Share by Application (2014-2019)
Figure Southeast Asia Ranibizumab Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ranibizumab Market Share (2018-2019)
Table Southeast Asia Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ranibizumab Market Share by Type (2014-2019)
Table Southeast Asia Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ranibizumab Market Share by Application (2014-2019)
Figure India Ranibizumab Market Size 2014-2019 (Million US$)
Table India Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table India Key Players Ranibizumab Market Share (2018-2019)
Table India Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table India Ranibizumab Market Share by Type (2014-2019)
Table India Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table India Ranibizumab Market Share by Application (2014-2019)
Figure Central & South America Ranibizumab Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ranibizumab Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ranibizumab Market Share (2018-2019)
Table Central & South America Ranibizumab Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ranibizumab Market Share by Type (2014-2019)
Table Central & South America Ranibizumab Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ranibizumab Market Share by Application (2014-2019)
Table Genentech Company Details
Table Genentech Revenue in Ranibizumab Business (2014-2019) (Million US$)
Figure Genentech Revenue Growth Rate in Ranibizumab Business (2014-2019)
Table Genentech Recent Development
Table Novartis Company Details
Table Novartis Revenue in Ranibizumab Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Ranibizumab Business (2014-2019)
Table Novartis Recent Development
Table Global Ranibizumab Market Size by Regions (Million US$) 2019-2025
Figure Global Ranibizumab Market Size Share by Regions (2019-2025)
Figure Global Ranibizumab Market Size Share by Regions in 2025
Figure United States Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure China Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure India Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ranibizumab Market Size Forecast (2019-2025)(Million USD)
Table Global Ranibizumab Market Size by Product (2019-2025) (Million US$)
Figure Global Ranibizumab Market Size by Product (2019-2025)
Figure Global Ranibizumab Market Size by Product in 2025
Table Global Ranibizumab Market Size by Application (2019-2025) (Million US$)
Figure Global Ranibizumab Market Size by Application (2019-2025)
Figure Global Ranibizumab Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…- 世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測 Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising …
- 世界の黄斑浮腫治療薬市場：市場規模・現状・予測 Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…
- 世界の増殖性糖尿病性網膜症市場2019 The global Proliferative Diabetic Retinopathy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Proliferative Diabetic Retinopathy market status and forecast, categorizes the global Proliferat…
- 世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測 Diabetic ketoacidosis is diagnosed by blood tests that show high levels of glucose, ketones and acid.In 2018, the global Diabetic Ketoacidosis Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report foc…